Andreasen, N (1983). The Scale for the Assessment of Negative Symptoms (SANS). The University of Iowa: Iowa City, IA.
Andreasen, N (1984). The Scale for the Assessment of Positive Symptoms (SAPS). The University of Iowa: Iowa City, IA.
Andreasen, NC, Nopoulos, P, Magnotta, V, Pierson, R, Ziebell, S, Ho, BC (2011). Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biological Psychiatry
70, 672–679.
Annett, M (1970). A classification of hand preference by association analysis. British Journal of Psychology
61, 303–321.
Arango, C, Moreno, C, Martinez, S, Parellada, M, Desco, M, Moreno, D, Fraguas, D, Gogtay, N, James, A, Rapoport, J (2008). Longitudinal brain changes in early-onset psychosis. Schizophrenia Bulletin
34, 341–353.
Arango, C, Rapado-Castro, M, Reig, S, Castro-Fornieles, J, Gonzalez-Pinto, A, Otero, S, Baeza, I, Moreno, C, Graell, M, Janssen, J, Parellada, M, Moreno, D, Bargallo, N, Desco, M (2012). Progressive brain changes in children and adolescents with first-episode psychosis. Archives of General Psychiatry
69, 16–26.
Asami, T, Bouix, S, Whitford, TJ, Shenton, ME, Salisbury, DF, McCarley, RW (2012). Longitudinal loss of gray matter volume in patients with first-episode schizophrenia: DARTEL automated analysis and ROI validation. NeuroImage
59, 986–996.
Boksa, P (2012). Abnormal synaptic pruning in schizophrenia: urban myth or reality?
Journal of Psychiatry and Neuroscience
37, 75–77.
Brans, RG, van Haren, NE, van Baal, GC, Schnack, HG, Kahn, RS, Hulshoff Pol, HE (2008). Heritability of changes in brain volume over time in twin pairs discordant for schizophrenia. Archives of General Psychiatry
65, 1259–1268.
Breslow, NE, Clayton, DG (1993). Approximate inference in generalized linear mixed models. Journal of the American Statistical Association
88, 9–25.
Buckner, RL, Head, D, Parker, J, Fotenos, AF, Marcus, D, Morris, JC, Snyder, AZ (2004). A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume. NeuroImage
23, 724–738.
Cobia, DJ, Smith, MJ, Wang, L, Csernansky, JG (2012). Longitudinal progression of frontal and temporal lobe changes in schizophrenia. Schizophrenia Research
139, 1–6.
Dale, AM, Fischl, B, Sereno, MI (1999). Cortical surface-based analysis. I. Segmentation and surface reconstruction. NeuroImage
9, 179–194.
Desikan, RS, Segonne, F, Fischl, B, Quinn, BT, Dickerson, BC, Blacker, D, Buckner, RL, Dale, AM, Maguire, RP, Hyman, BT, Albert, MS, Killiany, RJ (2006). An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage
31, 968–980.
Drake, RE, Osher, FC, Noordsy, DL, Hurlbut, SC, Teague, GB, Beaudett, MS (1990). Diagnosis of alcohol use disorders in schizophrenia. Schizophrenia Bulletin
16, 57–67.
Du, AT, Schuff, N, Kramer, JH, Rosen, HJ, Gorno-Tempini, ML, Rankin, K, Miller, BL, Weiner, MW (2007). Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Brain
130, 1159–1166.
Ellison-Wright, I, Glahn, DC, Laird, AR, Thelen, SM, Bullmore, E (2008). The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. American Journal of Psychiatry
165, 1015–1023.
Fischl, B, Dale, AM (2000). Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proceedings of the National Academy of Sciences USA
97, 11050–11055.
Fischl, B, Sereno, MI, Dale, AM (1999). Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. NeuroImage
9, 195–207.
Fusar-Poli, P, Smieskova, R, Kempton, MJ, Ho, BC, Andreasen, NC, Borgwardt, S (2013). Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. Neuroscience and Biobehavioral Reviews
37, 1680–1691.
Genovese, CR, Lazar, NA, Nichols, T (2002). Thresholding of statistical maps in functional neuroimaging using the false discovery rate. NeuroImage
15, 870–878.
Giedd, JN, Schmitt, JE, Neale, MC (2007). Structural brain magnetic resonance imaging of pediatric twins. Human Brain Mapping
28, 474–481.
Goghari, VM, Smith, GN, Honer, WG, Kopala, LC, Thornton, AE, Su, W, Macewan, GW, Lang, DJ (2013). Effects of eight weeks of atypical antipsychotic treatment on middle frontal thickness in drug-naive first-episode psychosis patients. Schizophrenia Research
149, 149–155.
Gutiérrez-Galve, L, Flugel, D, Thompson, PJ, Koepp, MJ, Symms, MR, Ron, MA, Foong, J (2012). Cortical abnormalities and their cognitive correlates in patients with temporal lobe epilepsy and interictal psychosis. Epilepsia
53, 1077–1087.
Gutiérrez-Galve, L, Wheeler-Kingshott, CA, Altmann, DR, Price, G, Chu, EM, Leeson, VC, Lobo, A, Barker, GJ, Barnes, TR, Joyce, EM, Ron, MA (2010). Changes in the frontotemporal cortex and cognitive correlates in first-episode psychosis. Biological Psychiatry
68, 51–60.
Hamilton, M (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry
23, 56–62.
Ho, BC, Andreasen, NC, Ziebell, S, Pierson, R, Magnotta, V (2011). Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Archives of General Psychiatry
68, 128–137.
Huddy, VC, Hodgson, TL, Kapasi, M, Mutsatsa, SH, Harrison, I, Barnes, TR, Joyce, EM (2007). Gaze strategies during planning in first-episode psychosis. Journal of Abnormal Psychology
116, 589–598.
Hulshoff Pol, HE, Kahn, RS (2008). What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophrenia Bulletin
34, 354–366.
Ivleva, EI, Bidesi, AS, Keshavan, MS, Pearlson, GD, Meda, SA, Dodig, D, Moates, AF, Lu, H, Francis, AN, Tandon, N, Schretlen, DJ, Sweeney, JA, Clementz, BA, Tamminga, CA (2013). Gray matter volume as an intermediate phenotype for psychosis: Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). American Journal of Psychiatry
170, 1285–1296.
Jablensky, A, McGrath, J, Herrman, H, Castle, D, Gureje, O, Evans, M, Carr, V, Morgan, V, Korten, A, Harvey, C (2000). Psychotic disorders in urban areas: an overview of the Study on Low Prevalence Disorders. Australian and New Zealand Journal of Psychiatry
34, 221–236.
Joyce, EM, Hutton, SB, Mutsatsa, SH, Barnes, TR (2005). Cognitive heterogeneity in first-episode schizophrenia. British Journal of Psychiatry
187, 516–522.
Khandaker, GM, Barnett, JH, White, IR, Jones, PB (2011). A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophrenia Research
132, 220–227.
Konopaske, GT, Dorph-Petersen, KA, Pierri, JN, Wu, Q, Sampson, AR, Lewis, DA (2007). Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys. Neuropsychopharmacology
32, 1216–1223.
Kuperberg, GR, Broome, MR, McGuire, PK, David, AS, Eddy, M, Ozawa, F, Goff, D, West, WC, Williams, SC, van der Kouwe, AJ, Salat, DH, Dale, AM, Fischl, B (2003). Regionally localized thinning of the cerebral cortex in schizophrenia. Archives General of Psychiatry
60, 878–888.
Leeson, VC, Sharma, P, Harrison, M, Ron, MA, Barnes, TR, Joyce, EM (2011). IQ trajectory, cognitive reserve, and clinical outcome following a first episode of psychosis: a 3-year longitudinal study. Schizophrenia Bulletin
37, 768–777.
Lezak, MD (1995). Neuropsychological Assessment. Oxford University Press: New York, NY.
Martin-Santos, R, Fagundo, AB, Crippa, JA, Atakan, Z, Bhattacharyya, S, Allen, P, Fusar-Poli, P, Borgwardt, S, Seal, M, Busatto, GF, McGuire, P (2010). Neuroimaging in cannabis use: a systematic review of the literature. Psychological Medicine
40, 383–398.
Minatogawa-Chang, TM, Schaufelberger, MS, Ayres, AM, Duran, FL, Gutt, EK, Murray, RM, Rushe, TM, McGuire, PK, Menezes, PR, Scazufca, M, Busatto, GF (2009). Cognitive performance is related to cortical grey matter volumes in early stages of schizophrenia: a population-based study of first-episode psychosis. Schizophrenia Research
113, 200–209.
Moncrieff, J, Leo, J (2010). A systematic review of the effects of antipsychotic drugs on brain volume. Psychological Medicine
40, 1409–1422.
Murray, GK, Corlett, PR, Fletcher, PC (2010). The neural underpinnings of associative learning in health and psychosis: how can performance be preserved when brain responses are abnormal?
Schizophrenia Bulletin
36, 465–471.
Murray, RM, Lewis, SW (1987). Is schizophrenia a neurodevelopmental disorder?
British Medical Journal (Clinical Research Edition)
295, 681–682.
Narr, KL, Bilder, RM, Toga, AW, Woods, RP, Rex, DE, Szeszko, PR, Robinson, D, Sevy, S, Gunduz-Bruce, H, Wang, YP, DeLuca, H, Thompson, PM (2005). Mapping cortical thickness and gray matter concentration in first episode schizophrenia. Cerebral Cortex
15, 708–719.
Nelson, H, Willson, J (1991). The Revised National Adult Reading Test (NART): Test Manual. NFER-Nelson: Windsor.
Owens, SF, Picchioni, MM, Ettinger, U, McDonald, C, Walshe, M, Schmechtig, A, Murray, RM, Rijsdijk, F, Toulopoulou, T (2012). Prefrontal deviations in function but not volume are putative endophenotypes for schizophrenia. Brain
135, 2231–2244.
Panizzon, MS, Fennema-Notestine, C, Eyler, LT, Jernigan, TL, Prom-Wormley, E, Neale, M, Jacobson, K, Lyons, MJ, Grant, MD, Franz, CE, Xian, H, Tsuang, M, Fischl, B, Seidman, L, Dale, A, Kremen, WS (2009). Distinct genetic influences on cortical surface area and cortical thickness. Cerebral Cortex
19, 2728–2735.
Perkins, DO, Leserman, J, Jarskog, LF, Graham, K, Kazmer, J, Lieberman, JA (2000). Characterizing and dating the onset of symptoms in psychotic illness: the Symptom Onset in Schizophrenia (SOS) inventory. Schizophrenia Research
44, 1–10.
Rais, M, Cahn, W, Van Haren, N, Schnack, H, Caspers, E, Hulshoff Pol, H, Kahn, R (2008). Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients. American Journal of Psychiatry
165, 490–496.
Reilly, JL, Sweeney, JA (2014). Generalized and specific neurocognitive deficits in psychotic disorders: utility for evaluating pharmacological treatment effects and as intermediate phenotypes for gene discovery. Schizophrenia Bulletin
40, 516–522.
Reuter, M, Fischl, B (2011). Avoiding asymmetry-induced bias in longitudinal image processing. NeuroImage
57, 19–21.
Reuter, M, Schmansky, NJ, Rosas, HD, Fischl, B (2012). Within-subject template estimation for unbiased longitudinal image analysis. NeuroImage
61, 1402–1418.
Roiz-Santianez, R, Tordesillas-Gutierrez, D, Ortiz-Garcia de la Foz, V, Ayesa-Arriola, R, Gutierrez, A, Tabares-Seisdedos, R, Vazquez-Barquero, JL, Crespo-Facorro, B (2012). Effect of antipsychotic drugs on cortical thickness. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine. Schizophrenia Research
141, 22–28.
Sahakian, BJ, Owen, AM (1992). Computerized assessment in neuropsychiatry using CANTAB: discussion paper. Journal of the Royal Society of Medicine
85, 399–402.
Schultz, CC, Koch, K, Wagner, G, Roebel, M, Schachtzabel, C, Gaser, C, Nenadic, I, Reichenbach, JR, Sauer, H, Schlosser, RG (2010). Reduced cortical thickness in first episode schizophrenia. Schizophrenia Research
116, 204–209.
Selemon, LD (2001). Regionally diverse cortical pathology in schizophrenia: clues to the etiology of the disease. Schizophrenia Bulletin
27, 349–377.
Sun, D, Stuart, GW, Jenkinson, M, Wood, SJ, McGorry, PD, Velakoulis, D, van Erp, TG, Thompson, PM, Toga, AW, Smith, DJ, Cannon, TD, Pantelis, C (2009). Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Molecular Psychiatry
14, 976–986.
Thompson, PM, Vidal, C, Giedd, JN, Gochman, P, Blumenthal, J, Nicolson, R, Toga, AW, Rapoport, JL (2001). Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proceedings of the National Academy of Sciences USA
98, 11650–11655.
Uranova, NA, Vostrikov, VM, Orlovskaya, DD, Rachmanova, VI (2004). Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophrenia Research
67, 269–275.
van Haren, NE, Cahn, W, Hulshoff Pol, HE, Kahn, RS (2012). The course of brain abnormalities in schizophrenia: can we slow the progression?
Journal of Psychopharmacology
26, 8–14.
van Haren, NE, Hulshoff Pol, HE, Schnack, HG, Cahn, W, Brans, R, Carati, I, Rais, M, Kahn, RS (2008). Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biological Psychiatry
63, 106–113.
van Haren, NE, Schnack, HG, Cahn, W, van den Heuvel, MP, Lepage, C, Collins, L, Evans, AC, Hulshoff Pol, HE, Kahn, RS (2011). Changes in cortical thickness during the course of illness in schizophrenia. Archives of General Psychiatry
68, 871–880.
Vernon, AC, Natesan, S, Modo, M, Kapur, S (2011). Effect of chronic antipsychotic treatment on brain structure: a serial magnetic resonance imaging study with ex vivo and postmortem confirmation. Biological Psychiatry
69, 936–944.
Vidal, CN, Rapoport, JL, Hayashi, KM, Geaga, JA, Sui, Y, McLemore, LE, Alaghband, Y, Giedd, JN, Gochman, P, Blumenthal, J, Gogtay, N, Nicolson, R, Toga, AW, Thompson, PM (2006). Dynamically spreading frontal and cingulate deficits mapped in adolescents with schizophrenia. Archives of General Psychiatry
63, 25–34.
Voets, NL, Hough, MG, Douaud, G, Matthews, PM, James, A, Winmill, L, Webster, P, Smith, S (2008). Evidence for abnormalities of cortical development in adolescent-onset schizophrenia. NeuroImage
43, 665–675.
Wechsler, D (1997). Wechsler Adult Intelligence Scale – 3rd Edition (WAIS-III). The Psychological Corporation: San Antonio, TX.
Wisco, JJ, Kuperberg, G, Manoach, D, Quinn, BT, Busa, E, Fischl, B, Heckers, S, Sorensen, AG (2007). Abnormal cortical folding patterns within Broca's area in schizophrenia: evidence from structural MRI. Schizophrenia Research
94, 317–327.
Young, RC, Biggs, JT, Ziegler, VE, Meyer, DA (1978). A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry
133, 429–435.
